Skip to content
Biotechnology and agriculture have evolved together. Since humanity first started farming, we have been working to impact soil, plants, animals, and microbes to secure […]
National Agriculture Day: Biotech and agriculture grow together Read More »
Whether it’s bottles, baby wipes, fashion, or fuel, biology can build it better. Biobased products, made from renewable natural materials, provide sustainable alternatives to
National Biobased Products Day: Building better with biology Read More »
The time has come for Congress to pass legislation to prevent pharmacy benefit managers (PBMs) from inflating drug costs, limiting patient access to drugs,
House members urge passage of reforms at PBM hearing Read More »
When it comes to biotech M&A, 2024 wasn’t a great year, but it wasn’t “horrible,” according to analysts at the BIO CEO & Investor
M&A comeback may face political headwinds, say BIO CEO panelists Read More »
As farmers, ranchers, and biotech companies work together to keep America strong and well-fed, they need supportive policy, an expert from the Biotechnology Innovation
BIO promotes its partnership with farmers and ranchers at Farm Bureau Convention Read More »
Seeking biotech-friendly policy from the new administration and Congress will be daunting and perhaps confusing, but there are still a lot of potential wins
BIO CEO 2025: Challenges and opportunities in the new administration Read More »
Colorado’s contributions to biotechnology innovation—and biotech’s importance to our health, food supply, and national security—were key themes as BIO President & CEO John F.
John Crowley highlights Colorado’s biotech ecosystem during packed Denver tour Read More »
Pictured: JOURNAVX bottle and tablet (Photo: Business Wire) The Jan. 30 approval of Vertex Pharmaceuticals’ JOURNAVX™ (suzetrigine), for acute pain, represents a watershed in
FDA approves Vertex’s pain treatment: A victory in the war against the opioid epidemic Read More »
Reforms to prevent middlemen from driving up drug prices and legislation encouraging the development of oral medications and rare disease treatments were called top
What BIO’s watching in the new Congress Read More »
The year in biotech M&A activity got off to a promising start at JPM Week with announcements of some multi-billion-dollar deals. The flurry of
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025 Read More »
